MNCs To Cash In Addition Of Smoking Cessation Drugs To EDL
This article was originally published in PharmAsia News
Executive Summary
Multinational pharma companies with smoking cessation products will benefit from the upcoming Chinese Essential Drug List, which will have such products added.